These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Thrombolysis in myocardial infarction (TIMI) randomized studies versus TIMI open label studies. Knatterud GL Control Clin Trials; 1989 Dec; 10(4 Suppl):245S-256S. PubMed ID: 2691212 [TBL] [Abstract][Full Text] [Related]
67. The status of research in invasive cardiology. Topol EJ J Invasive Cardiol; 1992; 4(1):10-7. PubMed ID: 10149902 [No Abstract] [Full Text] [Related]
68. Concerning to low molecular weight heparins (LMWHs) in acut coronary syndromes. Borja J; Olivella P S D J Med; 2000 Jul; 53(7):277-9. PubMed ID: 10932610 [No Abstract] [Full Text] [Related]
69. [Proposals for an outline of fibrinolytic-clearing therapy in coronary diseases]. Ferliga G G Gerontol; 1967 Jul; 15(7):813-26. PubMed ID: 5606218 [No Abstract] [Full Text] [Related]
70. Treatment of acute coronary syndromes: have we reached the ceiling? Wallentin L Nat Clin Pract Cardiovasc Med; 2005 Apr; 2(4):173. PubMed ID: 16265463 [No Abstract] [Full Text] [Related]
71. [Use of the new thrombolytic substance plasmakinase to treat acute experimental coronary artery thrombosis]. Khvatov VB; Galankina IE; Maksimovich IV Grudn Khir; 1983; (4):22-32. PubMed ID: 6354883 [No Abstract] [Full Text] [Related]
72. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels]. Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295 [No Abstract] [Full Text] [Related]
73. Guidelines for the management of acute coronary syndromes 2006. Little M; Johnstone C Med J Aust; 2007 Sep; 187(6):372; author reply 372. PubMed ID: 17874994 [No Abstract] [Full Text] [Related]
74. [Comparison of patterns of drug therapy in Hungary and in developed Western countries for acute coronary syndromes]. Keltai M Orv Hetil; 2000 Jun; 141(26):1449-53. PubMed ID: 10936933 [TBL] [Abstract][Full Text] [Related]
75. Thrombolytic therapy: just do it. Fendrick AM J Gen Intern Med; 1995 Jun; 10(6):351-2. PubMed ID: 7562128 [No Abstract] [Full Text] [Related]
76. [Invasive management of non-ST elevation acute coronary syndromes: lessons from RITA-3 and other randomised trials]. Henderson RA Rev Esp Cardiol; 2003 Sep; 56(9):836-42. PubMed ID: 14519268 [No Abstract] [Full Text] [Related]
77. Unfractionated heparin in acute coronary syndromes: has its time come and gone? Trujillo TC; Nolan PE Am J Health Syst Pharm; 1998 Nov; 55(22):2402-9. PubMed ID: 9825037 [No Abstract] [Full Text] [Related]
78. [Acetylsalicylic acid and acute coronary syndromes: the difficult art of clinical medicine]. Permanyer Miralda G Med Clin (Barc); 2000 Oct; 115(12):458-9. PubMed ID: 11093859 [No Abstract] [Full Text] [Related]
79. Dutch probiotics study is criticised for its "design, approval, and conduct". Sheldon T BMJ; 2010 Jan; 340():c77. PubMed ID: 20053835 [No Abstract] [Full Text] [Related]
80. Telematic-based model of early diagnosis and treatment of acute coronary syndromes. Griebenow R; Dang C Stud Health Technol Inform; 1999; 64():138-41. PubMed ID: 10747532 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]